| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 08/21/2002 | CN1365363A thineopyranecarboxyamide derivatives |
| 08/20/2002 | US6437132 Inhibitor of gonadotropin releasing hormone |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | CA2257222C Amide derivatives |
| 08/20/2002 | CA2240138C Quinazolin-4-one ampa antagonists |
| 08/20/2002 | CA2077695C Hydropyridine derivatives having antithrombotic activity |
| 08/15/2002 | WO2002062803A1 Thienopyrimidine derivative |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062764A1 Fused heterocyclic compounds |
| 08/15/2002 | WO2002062343A2 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS |
| 08/15/2002 | WO2002042244A3 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/15/2002 | CA2437492A1 Fused heterocyclic compounds |
| 08/15/2002 | CA2437085A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 08/14/2002 | EP1230244A2 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 08/14/2002 | EP1230225A2 Pharmaceutically active 4-substituted pyrimidine derivatives |
| 08/14/2002 | EP1229912A1 Protease inhibitors |
| 08/14/2002 | EP1229911A1 Protease inhibitors |
| 08/14/2002 | EP1087976B1 Polymorphic clopidogrel hydrogenesulphate form |
| 08/14/2002 | EP0722439B1 Hiv protease inhibitors |
| 08/14/2002 | DE10106457A1 DELTA·1·-Pyrroline DELTA · 1 · -Pyrrolines |
| 08/13/2002 | US6433167 Triazolo-1,4-diazepine compounds and medicinal composition containing the same |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6432964 Fungicides |
| 08/13/2002 | US6432955 Heterocyclic derivatives and their use as antithrombotic agents |
| 08/13/2002 | US6432943 Method for treating sexual dysfunction |
| 08/08/2002 | WO2002060906A2 Crystal modification of olanzapine |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060872A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/08/2002 | WO2002060858A1 Novel compound having maillard reaction inhibitory activity |
| 08/08/2002 | WO2002060449A2 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002024650A3 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 08/08/2002 | WO2002014269A3 2,4-substituted pyridine derivatives |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001064685A3 Thienopyridine derivatives and their use as anti-inflammatory agents |
| 08/08/2002 | US20020107411 Such as 25-hydroxy-3-aminopropoxyvitamin D3 biotinamide; kits |
| 08/08/2002 | US20020107402 Aminoaryl oxazolidinone N-oxides |
| 08/08/2002 | US20020107263 Squaric acid derivatives |
| 08/08/2002 | CA2436774A1 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | CA2436209A1 Pharmaceutical formulation containing pyrazolo[4,3-d]pyrimidine and nitrates or thienopyrimidines and nitrates |
| 08/08/2002 | CA2435545A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents |
| 08/07/2002 | EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 08/07/2002 | EP1228060A1 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 08/07/2002 | CN1362397A Dialkoyl-halogen phenyl substituted keto-enol |
| 08/07/2002 | CN1088709C Amine compound and its acid addition salt |
| 08/07/2002 | CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments |
| 08/06/2002 | US6429210 Orthorombic polymorph of clopidogrel hydrogen sulfate with improved stability and lower solubility; antithrombotic agent; specific crystal structure and thermodynamic properties |
| 08/06/2002 | CA2231812C Cyclic nitrones and pharmaceutical compositions containing them |
| 08/01/2002 | WO2002059128A2 Process for preparing clopidogrel |
| 08/01/2002 | WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors |
| 08/01/2002 | WO2002029409A3 Method of assaying pyrrole-containing biological compounds |
| 08/01/2002 | WO2002012227A3 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 08/01/2002 | US20020103376 Dithiepino[6,5-b]pyridines, and related compositions and methods |
| 08/01/2002 | US20020103234 Heterocycl-containing carboxylic acid derivative and drug containing the same |
| 08/01/2002 | US20020103230 Heterocyclic compounds |
| 08/01/2002 | US20020103213 Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis |
| 08/01/2002 | US20020102608 Library of indolinone compounds for use in the treatment of cancer |
| 07/31/2002 | EP1226193A2 Process for the preparation of ethylene polymers |
| 07/31/2002 | EP1226146A2 Quinoline and naphthyridine carboxylic acid antibacterials |
| 07/31/2002 | EP1226138A1 Fab i inhibitors |
| 07/31/2002 | EP1226122A1 Bicyclic vasopressin agonists |
| 07/31/2002 | EP1226119A2 Tyrosine kinase inhibitors |
| 07/31/2002 | EP0527801B1 Thiophene sulfonamides useful as carbonic anhydrase inhibitors |
| 07/31/2002 | CN1361779A New compounds |
| 07/31/2002 | CN1361774A Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 07/31/2002 | CN1361687A Phosphate transport inhibitors |
| 07/31/2002 | CN1360891A Dithiolane amylene hepyrroleketone and its relative monoxide and dioxide using as antitumour agent |
| 07/30/2002 | US6426350 Alpha-2 adrenoceptor antagonists; use treating nervous system disorders |
| 07/30/2002 | US6426023 Benzopyrans annelated in C7-C8 with an aromatic heterocycle and compositions and (CO)polymer matrices containing them |
| 07/30/2002 | CA2237357C Stable biotinylated biomolecule composition and methods |
| 07/25/2002 | WO2002057271A2 Thienopyrimidine-based inhibitors of the src family |
| 07/25/2002 | WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors |
| 07/25/2002 | WO2002057242A2 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | WO2002020529A8 METHOD FOR OBTAINING 4-(N-ALKYLAMINE)-5, 6-DIHYDRO-4H-THIENO-(2,3-b)-THIOPYRAN-2-SULFAMIDE-7, 7-DIOXIDES AND INTERMEDIATE PRODUCTS |
| 07/25/2002 | WO2002000653A3 Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 07/25/2002 | US20020099212 Sulfonamide compounds and pharmaceutical use thereof |
| 07/25/2002 | US20020099073 5-(Benzoylaminomethyl)-2-(oxalyl-amino)-4,5,6,7-tetrahydro -thieno(2,3-c)pyridine-3-carboxylic acid for example; useful treating diabetes, type 2 diabetes, impaired glucose tolerance, insulin resistance, obesity |
| 07/25/2002 | US20020099065 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents |
| 07/25/2002 | US20020099055 Novel compounds |
| 07/25/2002 | US20020098556 Generating preferential compound in culture; obtain genetically engineered bacteria, culturing, recover preferential compound |
| 07/25/2002 | DE10101397A1 New reagent for biotinylation of substrates, useful e.g. in medical research, comprises biotin linked to a solid particle through N-alkyl-N-acylsulfonamide |
| 07/25/2002 | CA2434939A1 Urea derivatives as integrin alpha 4 antagonists |
| 07/25/2002 | CA2426775A1 Thienopyrimidine-based inhibitors of the src family |
| 07/24/2002 | EP1224187A2 Certain alkylene diamine-substituted heterocycles |
| 07/24/2002 | EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method |
| 07/24/2002 | EP0820454B1 Anellated beta-carbolines |
| 07/24/2002 | CN1360582A Quinazoline derivs. |
| 07/23/2002 | US6423840 Forming n-acylamino compound |
| 07/23/2002 | US6423711 Useful in diagnosis and therapy of anxiety, down syndrome, sleep, cognitive and seizure disorders, and overdose with benzodiazepine drugs and for enhancement of alertness |
| 07/18/2002 | WO2002055524A1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002040455A8 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars) |
| 07/18/2002 | WO2002012249A3 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 07/18/2002 | WO2002000623A3 Aryl fused substituted 4-oxy-pyridines |
| 07/18/2002 | WO2001083480A3 Dihydropyridine compounds and methods of use |
| 07/18/2002 | US20020094999 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias |
| 07/18/2002 | US20020094977 Benzo(3,4)pyrido(3,2-a)cycloctenes and benzo(3,4)pyrido-(3,2-a)oxocins, -thiocins or azocines; anticholesterol, antilipemic agents; lowering LDL cholesterol; increasing HDl cholesterol; hypertriglyceridemia and atherosclerosis |
| 07/18/2002 | CA2434005A1 Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists |
| 07/17/2002 | EP1222193A2 Imidazole derivatives as phosphodiesterase vii inhibitors |